Leeds are closing in on an initial loan move for Nice defender Melvin Bard, with the deal containing an option to buy at the end of the season. Bard is travelling to Elland Road on deadline day to complete a medical, and Leeds are paying an initial one million euros for the loan, with a further five million euros due if they take up the option. He has already played 151 minutes this season for Nice and has made only two Ligue 1 appearances, which points to a player arriving with some rhythm rather than a long layoff.
Leeds' left side needs an extra body
The move is about a specific hole in the squad. Gabriel Gudmundsson is Leeds' only current left-sided option available to Daniel Farke, and he has been out injured. James Justin has been covering on the wrong side, so Bard gives Leeds a natural left-footer at a position where they have been stretched thin.
BBC Sport's reporting framed the need clearly: "The addition will add depth to the full-back positions with Gabriel Gudmundsson the only current left-sided option available to manager Daniel Farke." That is a straightforward case for acting before the window shuts, especially with Leeds still patching up their start to the season and mixed results in their last five.
Gnonto's exit is part of the same move
The Bard deal is also tied to the status of Wilfried Gnonto. The winger is in Florence completing a move to Fiorentina, but the initial loan is contingent on Leeds finding a replacement first. That is why the left-back move has become part of the same deadline-day chain rather than a separate piece of business.
BBC Sport also reported: "Leeds United are closing in on an initial loan move for Nice defender Melvin Bard, with the deal containing an option to buy the Frenchman at the end of the season." The fee structure is still being described in different ways across outlets, but the core line has stayed the same, Leeds want Bard in on loan, with a buy option, and they want the cover in place before Gnonto's move is allowed to progress.
Written by Jack Mercer with AI-assisted research, cross-checked against 3 outlets. How we work →
